Renovo Ltd.

"Evolutionary Service."
Mission Statement: To provide visionary medical services, within, and without, the box

Renovo Ltd. is a medical firm listed in New York City, USA, and led by a board of directors, each responsible for their individual divisions. Renovo is split into three main divisions, Acquisition, Research and Development, and Manufacture. The company is listed as a corporation with limited liability, allowing its members to be scrutinized only as far as their investment in the company. Currently, the three directors of the company hold 49% in public shares. A remaining 49% are distributed amongst competitors. 2% of shares are unaccounted for.

Division 1: Acquisition [Director: Tiffany Honors]
The acquisition divisions deals with the aggressive art of procuring resources - ingredients and materials - required for both research, development, and manufacturing. The director, Ms. Honors, who prefers to be known by her first name, Tiffany, is a tempestuous figure well known for her aggressive bargaining, and a fierce regard for environmental concerns despite her brutal pursuit of harvesting operations. Renovo outsources much of its acquisition, though. This is the smallest of the divisions.

Division 2: Research and Development (R&D) [Director: Howard R. Stokes]
Renovo's R&D division is one of the most secretive in the pharmaceutical field. This division handles the company's research and development efforts, which are currently focused around healing scar tissue, and by extension, other enhanced healing drugs. None of these drugs are currently slated for release. Renovo's R&D scored a perfect mark on its last external health and safety assessment. Howard Stokes is a conservative who used to work for DARPA (Defense Advanced Research Projects Agency,) not much is known about him except that he does everything in his power to meet all deadlines.

Division 3: Manufacturing [Director: Rafael Abbet]
Division Three is the newest addition to Renovo and is receiving the majority of Renovo's funding following several breakthroughs in the R&D division. Under the direction of Rafael, division three is preparing to manufacture and market two of its most successful treatments following extensive clinical trials. Despite the secrecy of Renovo, inspection of the company's internal workings have treated it to a stellar reputation. Many are anticipating the release of Renovo's first ground-breaking treatment. R&D is directed by Rafael Abbett, an enigmatic but kindly man of South African origin. He is a qualified doctor and renowned for experimental medicine.

Behind the PR
In the secret world, it's no surprise that each and everyone of these directors are members of the Illuminati. It's not hard to believe that such a lucrative company wouldn't be controlled by this American based society for the rich and passionate. To many it seems very cut and dry, Renovo is just a company dedicated to raking in profits for the illuminated ones.

Up until recently there has been talk by the higher ups that a new division is to be opening up in Renovo, one modeled after a group of monster hunters that was assigned to Blackwater International (A PMC which has roots in Blackwater USA.) But with the sudden absence of the group's leadership, every ounce of information has been wiped from the board. In that same day, Blackwater International's Division Four crumbled after virtually all of their three facilities went silent. Official reports say that each complex was destroyed in a rash of explosions.